RxDoctor Payments Data

Andrea Davis

Gerontology · Grand Junction, CONPI 1013489269

Payments from drug & device makers

What this record shows

17 manufacturers reported payments, led by Medtronic at 59.5% of the total. Reporting peaked in 2023 at $1,784 and has fallen 57.7% since, to $755 in 2025. Among gerontology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,666in general payments, 2019–2025

Across 67 payments — averaging $54.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Atricure, Inc.$717
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$259
  • Pfizer$88
  • Abbott$86
  • Johnson & Johnson$72
  • plus $263 from 11 others

What the payments were for

  • Travel & lodging$1,84050%
  • Food & beverage$1,82550%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,666 in reported general payments places this provider in the 90th percentile of 85 gerontology providers in Colorado.

See all gerontology providers in Colorado

Medicare billing

Part B allowed, 2024
$32,915
Medicare patients
313
Services billed
379

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban124$162,614
XareltoRivaroxaban27$31,458
EntrestoSacubitril/Valsartan13$16,509
FarxigaDapagliflozin Propanediol11$9,619
Dofetilide27$1,902
Metoprolol Succinate98$1,359
Diltiazem 24hr Er (Cd)Diltiazem Hcl26$993
Flecainide Acetate18$674
Amiodarone Hcl47$592
Atorvastatin Calcium39$261
Carvedilol60$252
Nitroglycerin14$246
Metoprolol Tartrate47$216
Furosemide37$191
Losartan Potassium30$184

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$88$162,614124 claims
Johnson & JohnsonXarelto$72$31,45827 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 85 gerontology providers in Colorado.

Other gerontology in Grand Junction

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →